Fas is detectable on β cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice

被引:43
作者
Darwiche, R
Chong, MMW
Santamaria, P
Thomas, HE
Kay, TWH
机构
[1] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[2] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
[3] Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB, Canada
[4] Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Calgary, AB, Canada
关键词
D O I
10.4049/jimmunol.170.12.6292
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas (CD95) is a potential mechanism of pancreatic beta cell death in type 1 diabetes. beta cells do not constitutively express. Fas but it is induced by cytokines. The hypothesis of this study is that Fas expression should be measurable on beta cells for them to be killed by this mechanism. We have previously reported that up to 5% of beta cells isolated from nonobese diabetic (NOD) mice are positive for Fas expression by flow cytometry using autofluorescence to identify beta cells. We have now found that these are not beta cells but contaminating dendritic cells, macrophages, and B lymphocytes. In contrast beta cells isolated from NODscid mice that are recipients of T lymphocytes from diabetic NOD mice express Fas 18-25 days after adoptive transfer but before development of diabetes. Fas expression on beta cells was also observed in BDC2.5, 8.3, and 4.1 TCR-transgenic models of diabetes in which diabetes occurs more rapidly than in unmodified NOD mice. In conclusion, Fas is observed on beta cells in models of diabetes in which rapid beta cell destruction occurs. Its expression is likely to reflect differences in the intraislet cytokine environment compared with the spontaneous model and may indicate a role for this pathway in beta cell destruction in rapidly progressive models.
引用
收藏
页码:6292 / 6297
页数:6
相关论文
共 28 条
[1]   Mechanisms of β cell death in diabetes:: A minor role for CD95 [J].
Allison, J ;
Strasser, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13818-13822
[2]   Perforin-independent β-cell destruction by diabetogenic CD8+ T lymphocytes in transgenic nonobese diabetic mice [J].
Amrani, A ;
Verdaguer, J ;
Anderson, B ;
Utsugi, T ;
Bou, S ;
Santamaria, P .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (08) :1201-1209
[3]   IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes [J].
Amrani, A ;
Verdaguer, J ;
T'hiessen, S ;
Bou, S ;
Santamaria, P .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :459-468
[4]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24
[5]   γ-interferon signaling in pancreatic β-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1 [J].
Chong, MMW ;
Thomas, HE ;
Kay, TWH .
DIABETES, 2001, 50 (12) :2744-2751
[6]   A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: Possible role of membrane TNF [J].
Herrera, PL ;
Harlan, DM ;
Vassalli, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :279-284
[7]   Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice [J].
Itoh, N ;
Imagawa, A ;
Hanafusa, T ;
Waguri, M ;
Yamamoto, K ;
Iwahashi, H ;
Moriwaki, M ;
Nakajima, H ;
Miyagawa, J ;
Namba, M ;
Makino, S ;
Nagata, S ;
Kono, N ;
Matsuzawa, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :613-618
[8]  
Kägi D, 1999, J IMMUNOL, V162, P4598
[9]   Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice [J].
Kagi, D ;
Odermatt, B ;
Seiler, P ;
Zinkernagel, RM ;
Mak, TW ;
Hengartner, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :989-997
[10]   OVEREXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ACCOMPANIES INSULITIS IN THE NONOBESE DIABETIC MOUSE AND IS PREVENTED BY ANTI-INTERFERON-GAMMA ANTIBODY [J].
KAY, TWH ;
CAMPBELL, IL ;
OXBROW, L ;
HARRISON, LC .
DIABETOLOGIA, 1991, 34 (11) :779-785